172 related articles for article (PubMed ID: 37189139)
1. Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer.
Cai J; Chen Y; Wang K; Li Y; Wu J; Yu H; Li Q; Wu Q; Meng W; Wang H; Lu A; Huang M; Wei G; Guan D
BMC Complement Med Ther; 2023 May; 23(1):158. PubMed ID: 37189139
[TBL] [Abstract][Full Text] [Related]
2. Shashen-Maidong Decoction inhibited cancer growth under intermittent hypoxia conditions by suppressing oxidative stress and inflammation.
Zheng Y; Yang S; Si J; Zhao Y; Zhao M; Ji E
J Ethnopharmacol; 2022 Dec; 299():115654. PubMed ID: 36058477
[TBL] [Abstract][Full Text] [Related]
3. Decoding the underlying mechanisms of Di-Tan-Decoction in treating intracerebral hemorrhage based on network pharmacology.
Zhen Z; Xue DJ; Chen YP; Li JH; Gao Y; Shen YB; Peng ZZ; Zhang N; Wang KX; Guan DG; Huang T
BMC Complement Med Ther; 2023 Feb; 23(1):44. PubMed ID: 36765346
[TBL] [Abstract][Full Text] [Related]
4. Shashen maidong decoction: the effect of TNF-α and IL-6 on lung cancer cachexia based on cancer toxicity theory.
He M; Luo Y; Chen L; Zeng M; Liao Q; Zhang W; Xie H
Am J Transl Res; 2021; 13(6):6752-6758. PubMed ID: 34306422
[TBL] [Abstract][Full Text] [Related]
5. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of Sijunzi Decoction in treatment of Alzheimer's disease based on UPLC-Q-TOF-MS, network pharmacology, and experimental verification].
Cai KZ; Zheng Q; Zhu XD; Wei SF; Wu MQ; Xiong H; Zhao HT
Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(6):1620-1631. PubMed ID: 37005850
[TBL] [Abstract][Full Text] [Related]
7. Screening of the key response component groups and mechanism verification of Huangqi-Guizhi-Wuwu-Decoction in treating rheumatoid arthritis based on a novel computational pharmacological model.
Liu Q; Luo Q; Fan Q; Li Y; Lu A; Guan D
BMC Complement Med Ther; 2024 Jan; 24(1):4. PubMed ID: 38166916
[TBL] [Abstract][Full Text] [Related]
8. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
[TBL] [Abstract][Full Text] [Related]
9. Systems pharmacology reveals the mechanism of activity of Ge-Gen-Qin-Lian decoction against LPS-induced acute lung injury: A novel strategy for exploring active components and effective mechanism of TCM formulae.
Ding Z; Zhong R; Yang Y; Xia T; Wang W; Wang Y; Xing N; Luo Y; Li S; Shang L; Shu Z
Pharmacol Res; 2020 Jun; 156():104759. PubMed ID: 32200026
[TBL] [Abstract][Full Text] [Related]
10. Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer.
Jiao P; Wang Y; Ren G; Chu D; Li Y; Sang T
Biomed Res Int; 2023; 2023():4967544. PubMed ID: 36874921
[TBL] [Abstract][Full Text] [Related]
11. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
12. Systemic pharmacological verification of Baixianfeng decoction regulating TNF-PI3K-Akt-NF-κB pathway in treating rheumatoid arthritis.
Wei X; Zhou R; Chen Y; Ma G; Yang Y; Lu C; Xu W; Hu W
Bioorg Chem; 2022 Feb; 119():105519. PubMed ID: 34864624
[TBL] [Abstract][Full Text] [Related]
13. Detecting Key Functional Components Group and Speculating the Potential Mechanism of Xiao-Xu-Ming Decoction in Treating Stroke.
Chen YP; Wang KX; Cai JQ; Li Y; Yu HL; Wu Q; Meng W; Wang HD; Yin CH; Wu J; Huang MB; Li R; Guan DG
Front Cell Dev Biol; 2022; 10():753425. PubMed ID: 35646921
[TBL] [Abstract][Full Text] [Related]
14. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
15. Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma.
Zhao XY; Yang YY; Feng JL; Feng CL
J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939253
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy and Safety of Shashen-Maidong Decoction Combined with Western Medicine in the Treatment of Omicron Infected Individuals Over 85 Years Old: A Retrospective Study.
Lin XX; Yin YQ; Zhang WZ; Huang JH; Hu WS
Infect Drug Resist; 2023; 16():7339-7348. PubMed ID: 38045652
[TBL] [Abstract][Full Text] [Related]
17. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment.
Wang K; Miao X; Kong F; Huang S; Mo J; Jin C; Zheng Y
Drug Des Devel Ther; 2021; 15():3749-3764. PubMed ID: 34511884
[TBL] [Abstract][Full Text] [Related]
18. Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer.
Zhang X; Zhu J; Yan J; Xiao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
Phytomedicine; 2020 Dec; 79():153326. PubMed ID: 32992083
[TBL] [Abstract][Full Text] [Related]
19. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
